3,368
Views
28
CrossRef citations to date
0
Altmetric
Research Article

Magnetic resonance imaging of tumor necrosis

, , &
Pages 427-434 | Received 30 Apr 2010, Accepted 18 Sep 2010, Published online: 18 Oct 2010

References

  • Jain RK. Determinants of tumor blood flow: A review. Cancer Res 1988;48:2641–58.
  • Steel GG. Growth kinetics of tumors. Oxford UK: Clarendon Press; 1977.
  • Vaupel P, Kallinowski F, Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: A review. Cancer Res 1989;49:6449–65.
  • Fenton BM, Kiani MF, Siemann DW. Should direct measurements of tumor oxygenation relate to the radiobiological hypoxic fraction of a tumor? Int J Radiat Oncol Biol Phys 1995;33:365–73.
  • Verheij M. Clinical biomarkers and imaging for radiotherapy-induced cell death. Cancer Metastasis Rev 2008;27: 471–80.
  • Toms AP, White LM, Kandel R, Bleakney RR, Noseworthy M, Lee S, . Limitations of single slice dynamic contrast enhanced MR in pharmacokinetic modeling of bone sarcomas. Acta Radiol 2009;50:512–20.
  • Jakobsen I, Kaalhus O, Lyng H, Rofstad EK. Detection of necrosis in human tumour xenografts by proton magnetic resonance imaging. Br J Cancer 1995;71:456–61.
  • Vossen JA, Buijs M, Geschwind JF, Liapi E, Prieto V, Lee KH, . Diffusion-weighted and Gd-EOB-DTPA-contrast-enhanced magnetic resonance imaging for characterization of tumor necrosis in an animal model. J Comput Assist Tomogr 2009;33:626–30.
  • Kettelhack C, Wickede M, Vogl T, Schneider U, Hohenberger P. 31Phosphorus-magnetic resonance spectroscopy to assess histologic tumor response noninvasively after isolated limb perfusion for soft tissue tumors. Cancer 2002;94:1557–64.
  • Bremer C, Bankert J, Filler T, Ebert W, Tombach B, Reimer P. High-dose Gd-DTPA vs. Bis-Gd-mesoporphyrin for monitoring laser-induced tissue necrosis. J Magn Reson Imaging 2005;21:801–8.
  • Metz S, Daldrup-Unk HE, Richter T, Räth C, Ebert W, Settles M, . Detection and quantification of breast tumor necrosis with MR imaging: Value of the necrosis-avid contrast agent Gadophrin-3. Acad Radiol 2003;10:484–90.
  • Benjaminsen IC, Graff BA, Brurberg KG, Rofstad EK. Assessment of tumor blood perfusion by high-resolution dynamic contrast-enhanced MRI: A preclinical study of human melanoma xenografts. Magn Reson Med 2004;52: 269–76.
  • Graff BA, Benjaminsen IC, Brurberg KG, Ruud EBM, Rofstad EK. Comparison of tumor blood perfusion assessed by dynamic contrast-enhanced MRI with tumor blood supply assessed by invasive imaging. J Magn Reson Imaging 2005;21:272–81.
  • Vestvik IK, Egeland TA, Gaustad JV, Mathiesen B, Rofstad EK. Assessment of microvascular density, extracellular volume fraction, and radiobiological hypoxia in human melanoma xenografts by dynamic contrast-enhanced MRI. J Magn Reson Imaging 2007;26:1033–42.
  • Benjaminsen IC, Brurberg KG, Ruud EBM, Rofstad EK. Assessment of extravascular extracellular space fraction in human melanoma xenografts by DCE-MRI and kinetic modeling. Magn Reson Imaging 2008;26:160–70.
  • Egeland TAM, Simonsen TG, Gaustad JV, Gulliksrud K, Ellingsen C, Rofstad EK. Dynamic contrast-enhanced magnetic resonance imaging of tumors: Preclinical validation of parametric images. Radiat Res 2009;172:339–47.
  • Egeland TAM, Gaustad JV, Benjaminsen IC, Hedalen K, Mathiesen B, Rofstad EK. Assessment of fraction of hypoxic cells in human tumor xenografts with necrotic regions by dynamic contrast-enhanced MRI. Radiat Res 2008;169:689–99.
  • Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, Knopp MV, . Estimating kinetic parameters from dynamic contrast-enhanced T1-weighted MRI of a diffusable tracer: Standardized quantities and symbols. J Magn Reson Imaging 1999;10:223–32.
  • Hittmair K, Gomiscek G, Langenberger K, Recht M, Imhof H, Kramer J. Method for the quantitative assessment of contrast agent uptake in dynamic contrast-enhanced MRI. Magn Reson Med 1994;31:567–71.
  • Mayr NA, Yuh WT, Arnholt JC, Ehrhardt JC, Sorosky JI, Magnotta VA, . Pixel analysis of MR perfusion imaging in predicting radiation therapy outcome in cervical cancer. J Magn Reson Imaging 2000;12:1027–33.
  • Loncaster JA, Carrington BM, Sykes JR, Jones AP, Todd SM, Cooper R, . Prediction of radiotherapy outcome using dynamic contrast-enhanced MRI of carcinoma of the cervix. Int J Radiat Oncol Biol Phys 2002;54:759–67.
  • Morgan B, Utting JF, Higginson A, Thomas AL, Steward WP, Horsfield MA. A simple, reproducible method for monitoring the treatment of tumours using dynamic contrast-enhanced MR imaging. Br J Cancer 2006;94:1420–7.
  • Nielsen T, Murata R, Maxwell RJ, Stødkilde-Jørgensen H, Østergaard L, Horsman MR. Preclinical studies to predict efficacy of vascular changes induced by combretastatin A-4 disodium phosphate in patients. Int J Radiat Oncol Biol Phys 2008;70:859–66.
  • Viertl D, Delaloye AB, Lanz B, Poitry-Yamate C, Gruetter R, Mlynarik V, . Increase of [18F]FLT tumor uptake in vivo mediated by FdUrd: Toward improving cell proliferation positron emission tomography. Mol Imaging Biol 2010, June 16 [Epub ahead of print]. DOI: 10.1007/s11307-010-0368-z.
  • Mima K, Hirota M, Abe S, Iwatsuki M, Imamura H, Tsuruzoe S, . Small solid pseudopapillary tumor of the pancreas in a 32-year-old man: Report of a case. Surg Today 2010;40:772–6.
  • DeJordy JO, Bendel P, Horowitz A, Salomon Y, Degani H. Correlation of MR imaging and histologic findings in mouse melanoma. J Magn Reson Imaging 1992;2:695–700.
  • Lyng H, Haraldseth O, Rofstad EK. Measurement of cell density and necrotic fraction in human melanoma xenografts by diffusion weighted magnetic resonance imaging. Magn Reson Med 2000;43:828–36.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.